SCHEMBL3608242

SCHEMBL3608242

CCC(=O)/C=C/C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12648287 1.00
SCHEMBL2728624 1.00
SCHEMBL11105090 0.87 ALDH1A1 (0.56)
SCHEMBL11105098 0.87 ALDH1A1 (0.56)
SCHEMBL19633528 0.83 PPARA (0.45)
Fumaric Acid SCHEMBL10381001 0.81 FFAR3 (0.67)
Maleic Acid SCHEMBL10381000 0.81 FFAR3 (0.67)
Fumaric Acid SCHEMBL15794260 0.81 TSHR (0.69)
Fumaric Acid SCHEMBL4237189 0.81 TSHR (0.69)
Maleic Acid SCHEMBL4240001 0.81 TSHR (0.69)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112094181-A Synthesis method and application of 4-oxo-trans-2-hexenal analogue 中国农业科学院植物保护研究所 2020-12-18 CN claimed
CN-113004269-B Heterocyclic compounds of Kras-G12C inhibitors 首药控股(北京)股份有限公司 2024-11-05 CN disclosed
EP-3035929-B1 7A-AMIDE SUBSTITUTED-6,6-DIFLUORO BICYCLIC HIMBACINE DERIVATIVES MERCK SHARP & DOHME LLC (US) 2024-07-03 EP disclosed
EP-3035928-B1 3'-PYRIDYL SUBSTITUTED- 6,6-DIFLUORO BICYCLIC HIMBACINE DERIVATIVES MERCK SHARP & DOHME LLC (US) 2023-10-18 EP disclosed
CN-112094181-B Synthesis method and application of 4-oxo-trans-2-hexenal analogue 中国农业科学院植物保护研究所 2022-07-19 CN disclosed
CN-112094181-B Synthesis method and application of 4-oxo-trans-2-hexenal analogue 中国农业科学院植物保护研究所 2022-07-19 CN disclosed
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
US-11116212-B2 Carbonyl containing compounds for controlling and repelling Cimicidae populations SEMIOSBIO TECHNOLOGIES INC. (CA) 2021-09-14 US disclosed
CN-113004269-A Heterocyclic compounds as Kras-G12C inhibitors 首药控股(北京)有限公司 2021-06-22 CN disclosed
CN-112094181-A Synthesis method and application of 4-oxo-trans-2-hexenal analogue 中国农业科学院植物保护研究所 2020-12-18 CN disclosed
US-20100041693-A1 INDOLYLMALEIMIDE DERIVATIVES NOVARTIS AG (CH) 2010-02-18 US disclosed
EP-2094689-A2 INDOLYLMALEIMIDE DERIVATIVES AS KINASE INHIBITORS Novartis AG (CH) 2009-09-02 EP disclosed
US-7572795-B2 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-11 US disclosed
US-7566787-B2 Small molecule cyclin D1 ablative agents THE OHIO STATE UNIVERSITY (US) 2009-07-28 US disclosed
US-20090156555-A1 PYRROLOTRIAZINE ANILINE PRODRUG COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2009-06-18 US disclosed
WO-2008074752-A2 INDOLYLMALEIMIDE DERIVATIVES AS KINASE INHIBITORS NOVARTIS AG (CH) 2008-06-26 WO disclosed
US-20070213300-A1 PYRROLOTRIAZINE ANILINE PRODRUG COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2007-09-13 US disclosed
US-20050032874-A1 Anticholesterol agents; arteriosclerosis BAYER AKTIENGESELLSCHAFT (DE) 2005-02-10 US disclosed
US-6794406-B2 FOR THERAPY AND PROPHYLAXIS OF ARTERIOSCLEROSIS AND HYPERCHOLESTEROLAEMIA BAYER AKTIENGESELLSCHAFT (DE) 2004-09-21 US disclosed
US-20030078288-A1 Indole derivatives BAYER AKTIENGESELLSCHAFT (DE) 2003-04-24 US disclosed